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Objective: To compare the association between
different anthropometric measurements and incident type
2 diabetes mellitus (T2DM) and to assess their predictive
ability in different regions of Germany.
Methods: Data of 10 258 participants from 4
prospective population-based cohorts were pooled to
assess the association of body weight, body mass index
(BMI), waist circumference (WC), waist-to-hip-ratio
(WHR) and waist-to-height-ratio (WHtR) with incident
T2DM by calculating HRs of the crude, adjusted and
standardised markers, as well as providing receiver
operator characteristic (ROC) curves. Differences between
HRs and ROCs for the different anthropometric markers
were calculated to compare their predictive ability. In
addition, data of 3105 participants from the nationwide
survey were analysed separately using the same methods
to provide a nationally representative comparison.
Results: Strong associations were found for each
anthropometric marker and incidence of T2DM. Among
the standardised anthropometric measures, we found the
strongest effect on incident T2DM for WC and WHtR in
the pooled sample (HR for 1 SD difference in WC 1.97,
95% CI 1.75 to 2.22, HR for WHtR 1.93, 95% CI 1.71 to
2.17 in women) and in female DEGS participants (HR for
WC 2.24, 95% CI 1.91 to 2.63, HR for WHtR 2.10, 95%
CI 1.81 to 2.44), whereas the strongest association in
men was found for WHR among DEGS participants
(HR 2.29, 95% CI 1.89 to 2.78). ROC analysis
showed WHtR to be the strongest predictor for
incident T2DM. Differences in HR and ROCs between the
different markers confirmed WC and WHtR to be
the best predictors of incident T2DM. Findings were
consistent across study regions and age groups
(<65 vs ≥65 years).
Conclusions:We found stronger associations between
anthropometric markers that reflect abdominal obesity
(ie, WC and WHtR) and incident T2DM than for BMI and
weight. The use of these measurements in risk prediction
should be encouraged.
INTRODUCTION
During the last decades, the prevalence and
incidence of type 2 diabetes mellitus
(T2DM) globally as well as within Germany
has risen dramatically.1 2 This cannot be
explained by demographic change alone.3
This development is even more worrying
when considering the severe complications
Strengths and limitations of this study
▪ We investigated commonly used anthropometric
markers to assess their association with incident
type 2 diabetes mellitus (T2DM).
▪ We used a pooled study population consisting of
four prospective, population-based cohorts from
different regions of Germany and one nationwide
survey.
▪ We used standardised measuring protocols for
anthropometric markers measured by specifically
trained and certified study nurses in the study
centres.
▪ Self-report of physician-diagnosed T2DM as
opposed to physician-verified diagnosis can be
considered a limitation.
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and secondary diseases associated with T2DM, leading
to higher mortality rates in patients with diabetes com-
pared with non-diabetic individuals.4 It is estimated that
nearly half of T2DM cases are not even diagnosed, and
thus remain untreated.5 The observed rise of T2DM
prevalence and incidence leads to considerable
increases in costs of healthcare.2 6
T2DM is a major public health issue that needs to be
explored in terms of aetiology, prevention and early
disease detection. In previous analyses, we found large
regional differences in the prevalence and incidence of
T2DM across Germany,7 8 as well as disparities in body
fat distribution.9
There is some evidence that the association of
anthropometric measurements with T2DM risk varies
across markers. For example, unfavourable body fat dis-
tribution has been found to be more strongly associated
with T2DM than increased body mass index (BMI)
alone.10 The underlying mechanism is thought to
involve visceral adipose tissue, which on one hand serves
as an energy reserve, and on the other hand seems to
be of importance in endocrine pathways.11 However,
studies investigating this topic often only used cross-
sectional data,12–14 had limitations of methods15 or inves-
tigated only a limited number of anthropometric
factors.16 17 Moreover, their results were not always con-
sistent. The objective of this work was on one hand to
describe the relation of each of the established
anthropometric markers with incident T2DM, and on
the other hand to elucidate whether there is an advan-
tage of using one of these markers above the others
when estimating the risk of incident T2DM, as this is still
uncertain. Therefore, we investigated the association of
each of the currently established standard anthropomet-
ric markers with incident T2DM and examined whether
the observed results are consistent across different
regions and age groups.
METHODS
Study population
We included data of four population-based longitudinal
cohort studies from different regions of Germany: the
Cardiovascular Disease, Living and Ageing in Halle
(CARLA) Study conducted in East Germany in the city
of Halle (Saale), the Study of Health in Pomerania
(SHIP) in the North-East, the Heinz Nixdorf Recall
Study (RECALL) in the western part of Germany and
the Cooperative Health Research in the Region of
Augsburg (KORA) F4 Survey from the south of
Germany. Detailed information on the design and
methods of these studies has already been described
elsewhere.18–22 In brief, the baseline investigations were
conducted between 1997 and 2006, with baseline
responses between 56% and 69%. The follow-up investi-
gations were performed between 2002 and 2010, result-
ing in observation times between 3.3 and 8.6 years.
Participation rate at follow-up, calculated as the ratio of
the number of participants at follow-up and the number
of participants at baseline minus the number of partici-
pants who died or withdrew, varied from 75% to 84%.
In addition, we used data from the national German
Health Interview and Examination Survey for Adults
(DEGS), which combines a nationally representative
health survey and a longitudinal follow-up of partici-
pants from the previous German National Health
Interview and Examination Survey in 1997–1999
(GNHIES98). For the present analysis, we only included
participants from GNHIES98 who also participated in
the follow-up examination (called DEGS). The baseline
response of GNHIES98 was 61%23 24 and the average
follow-up time 12.1 years, with a follow-up response of
47%. We analysed DEGS separately from the other
studies since its nationwide survey design and sampling
procedures with a longitudinal element differs methodo-
logically from the regional cohorts described above.
All studies used a standardised computer-assisted, per-
sonal interview, self-administered questionnaires and
standardised medical examinations at baseline. The
study procedures were described in standard operating
protocols, and staff was speciﬁcally trained and certiﬁed
prior to conducting the anthropometric measurements:
continuous measures of quality control ensured adher-
ence to the standardised examination methods.
Figure 1 shows the reasons for exclusion of partici-
pants from the present analyses in the pooled sample
and in DEGS. We excluded participants with prevalent
diabetes at baseline, participants with incomplete infor-
mation regarding T2DM at baseline or follow-up and
participants aged under 31 years at baseline, to avoid
inclusion of cases of type 1 diabetes mellitus.
Definition of T2DM
T2DM at baseline and follow-up was deﬁned based on
self-reported physician-diagnosed diabetes or self-
reported current intake of antidiabetic medication
during the 7 days prior to the examination, which was
coded according to the Anatomical Therapeutic
Chemical (ATC) Classiﬁcation system code as A10.
Measurement of anthropometric markers and covariates at
baseline
Body height, weight, waist circumference (WC) and hip
circumference (HC) were measured with comparable
standardised methods in CARLA, SHIP, RECALL and
KORA. Data on weight and height were collected using
Seca’s measuring systems (Seca GmbH & Co, KG,
Hamburg, Germany) for CARLA, RECALL, KORA and
DEGS. In SHIP, devices from Soehnle (LEIFHEIT AG,
Nassau, Germany) were used. WC and HC were mea-
sured using a ﬂexible, inelastic tape measure. WC was
measured at the narrowest part between the lowest ribs
and the highest point of the iliac crest. HC was mea-
sured at the largest circumference between the iliac
crest and the crotch in CARLA, SHIP, KORA and DEGS.
In RECALL, HC was measured at the middle between
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the iliac crest and the crotch. The indices of BMI,
waist-to-hip-ratio (WHR) and waist-to-height-ratio
(WHtR) were calculated as follows:
BMI ¼ weight ½kg
height2½m2
WHR ¼ waist circumference ½cm
hip circumference ½cm
WHtR ¼ waist circumference ½cm
height ½cm
Information on lifestyle factors, such as smoking,
alcohol consumption and physical activity, as well as on
socioeconomic data, was collected during the baseline
interview. Socioeconomic status was classiﬁed according
to the International Standard Classiﬁcation of Education
1997 (including school and professional education and
providing the total number of years of education).25
Information on current smoking status, duration of
smoking and number of cigarettes smoked was com-
bined to calculate pack years of cigarettes (1 pack year
≙20 cigarettes smoked per day for 1 year). Alcohol con-
sumption was dichotomised as no or moderate con-
sumption (♀: 0–10 g/day; ♂: 0–20 g/day) versus
consumption above these limits.26 Sports activities
during leisure time were categorised as regular sports
activities of at least 1 h per week versus <1 h of sports
activities per week. Dietary habits were collected using
validated food frequency questionnaires,27 28 either
during the personal interview (in KORA, SHIP and
RECALL) or through a self-administered questionnaire
(CARLA and DEGS). Based on the German Nutrition
Society’s recommendations,29 a simple score was gener-
ated based on information regarding brown bread
intake, red meat intake, and fruit and vegetable con-
sumption, as these nutritional components are known to
be associated with T2DM.30–32 For each of these compo-
nents, the participant received one score-point if the
intake met the recommendations. The resulting
summary score ranged from ‘0’ to ‘3’, with each score-
point corresponding to one item that met the
recommendations.
Statistical approach
The crude individual data of CARLA, SHIP, RECALL
and KORA were pooled into one data set. All described
analyses were also conducted for DEGS, where the data
had to be weighted to reduce inﬂuence of drop-out on
the association analyses since 38% of GNHIES98 survey
participants did not participate in the follow-up examin-
ation during the DEGS study. The study-speciﬁc weight-
ing factor was calculated by inverse probability
weighting.33 A stepwise regression approach was used to
Figure 1 Study population and exclusions (T2DM, type 2 diabetes mellitus).
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model potential predictors of dropout. Furthermore, the
weighting factor corrects sample deviations from popula-
tion structure with regard to age, sex, region, nationality,
community and education (as of 31 December 1997).34
Missing values in pack years (logarithmically trans-
formed for the imputation process) (n=92), alcohol con-
sumption (n=205), physical activity (n=21) and
education (n=11) were replaced by imputed values
derived from a series of 10 imputation data sets and age,
sex, study region and examination date as additional
explanatory variables.35 Participants with missing values
for anthropometric variables were excluded from the
speciﬁc analyses using these variables. For calculation of
incidence rates, we used the complete observation time
for participants without incident T2DM, and one-half of
the individual recorded observation time between base-
line and follow-up for participants with incident T2DM,
as we did not always know the exact date of diagnosis.
We estimated HRs and the corresponding 95% CIs for
the association of the respective anthropometric meas-
urement with incidence of T2DM. To be able to compare
the effects of the diverse markers with each other despite
the use of different scales, we standardised anthropomet-
ric markers to a mean of 0 and a SD of 1, before estimat-
ing the association of the diverse markers and incidence
of T2DM. In addition, we calculated the differences of
HR and receiver operator characteristic (ROC) area
under the curve (AUC) between the respective anthropo-
metric markers and weight in order to provide a measure
for the comparison of their predictive ability.
Owing to lack of information on the exact diagnosis
date of T2DM, we used a method for interval-censored
time-to-event data. Age was used as time scale with age at
the baseline as entry time. In a so-called delayed entry
study, participants are not observed until they are
included in the study. Assuming that age at diabetes
onset follows a Weibull distribution, we set up a propor-
tional hazards model. This is similar to a generalised
linear model, but includes a non-linear term in the
Weibull distribution for individual ages at baseline and
at follow-up, as described by Jain et al.36 The propor-
tional hazard assumptions were checked by visual inspec-
tion of residuals.
Analyses were adjusted for a variety of confounders
that were selected using directed acyclic graphs.37
In addition, we stratiﬁed the data set (1) by study region
and (2) by age (<65 vs ≥65 years) to examine the consist-
ency of the effects. To compare the pooled effects derived
from the pooled data analyses of the four regional studies
with the results of the nationwide DEGS study, we con-
ducted an age-stratiﬁed meta-analysis using Review
Manager 5.3 (Cochrane Collaboration, Oxford, England).
Furthermore, we calculated ROC curves individually
for all anthropometric measures and compared the
AUC by calculating AUC differences (±95% CI).
All analyses except for the meta-analyses, were con-




The ﬁnal pooled study population consisted of 10 258
individuals, 50.9% of whom were women. In DEGS,
53.4% of the 3.105 participants were female.
Table 1 summarises the baseline characteristics of the
study population including important risk and protective
factors for T2DM. The mean age in the pooled sample
was 55.5 years, ranging from 50.5 years in KORA to
62.2 years in CARLA. The mean BMI was 27.5 kg/m²,
and 24.4% of all participants were obese (BMI≥30 kg/m²)
as classiﬁed by WHO 2000. In DEGS, mean BMI was
26.9 kg/m² (ie, in the overweight category according to
WHO deﬁnition), but fewer participants were obese
(20.3%). Participants with incident T2DM showed a
more unfavourable risk factor proﬁle than those without
T2DM in all studies, and among men and women. For
example, they showed higher values for all anthropomet-
ric measures (except for baseline height), reported a
higher number of pack years and were less physically
active as compared with participants without incident
T2DM.
Differences across the study regions were found for
age, anthropometric measures and lifestyle character-
istics. Participants in CARLA had the highest WC
(98.1 cm), although weight and BMI were comparable
between the studies. In the DEGS study, participants
were slightly younger (mean age 48.1 years) and were
less likely to play sports for >1 h/week (39.6%) com-
pared with participants in the pooled sample. Education
levels and anthropometric measurements were compar-
able between the pooled sample and DEGS.
Of all participants included in the pooled study
sample, 595 developed T2DM during the follow-up,
resulting in an incidence rate of 10.8/1000 person years
(py) (95% CI 9.9 to 11.6). In DEGS, 267 participants
developed T2DM resulting in an incidence rate of 7.5/
1000 py (95% CI 6.6 to 8.3).
Association between anthropometric markers and
incidence of T2DM
Table 2 shows the standardised effects of the different
anthropometric markers on the incidence of T2DM with
adjustment for education, study region and the lifestyle
factors alcohol consumption, pack years of cigarettes,
sports activities and nutritional score. We found consist-
ent moderate associations for each anthropometric
marker with incident T2DM. When comparing the stan-
dardised anthropometric markers, in the pooled ana-
lyses, the measurements reﬂecting abdominal obesity
(WC, WHtR) showed stronger associations with incident
T2DM compared with body weight and BMI (table 2) in
both sexes. An exception was WHR, which showed the
weakest association with incidence of T2DM in women
and in men. The observed differences of HR and ROC
AUC with the respective CIs support this interpretation.
In women, an increase of 1 SD (=12.4 cm) in WC
resulted in a HR of 1.97 (95% CI 1.75 to 2.22), whereas
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Age (years) Mean (SD) 54.76 (±11.33) 60.66 (±9.63) 47.40 (±10.85) 53.79 (±10.70)
Observation period (years) Mean (SD) 5.57 (±1.06) 5.46 (±1.05) 12.09 (±1.00) 12.14 (±0.91)
Anthropometry
Height (m) Mean (SD) 1.62 (±0.06) 1.61 (±0.07) 1.63 (±0.06) 1.62 (±0.07)
Weight (kg) Mean (SD) 70.82 (±12.86) 80.26 (±16.04) 69.39 (±12.40) 81.64 (±17.99)
BMI (kg/m²) Mean (SD) 26.96 (±4.85) 30.96 (±5.72) 26.00 (±4.68) 31.18 (±6.18)
Waist circumference (cm) Mean (SD) 85.82 (±12.18) 97.12 (±13.01) 83.75 (±11.59) 97.29 (±13.97)
Hip circumference (cm) Mean (SD) 103.75 (±10.52) 110.79 (±11.90) 104.85 (±9.80) 114.12 (±12.98)
WHR Mean (SD) 0.83 (±0.07) 0.88 (±0.06) 0.80 (±0.06) 0.85 (±0.06)
WHtR Mean (SD) 0.53 (±0.08) 0.60 (±0.08) 0.51 (±0.07) 0.60 (±0.09)
Lifestyle
Smoking (pack years) Mean (SD) 6.69 (±12.67) 7.63 (±16.10) 5.90 (±10.77) 5.60 (±11.40)
No or moderate alcohol consumption (≤10 g/day) n (%) 3955 (81.08) 207 (89.61) 1278 (85.31) 121 (90.98)
Sports activities (≥1 h/week) n (%) 2392 (48.04) 85 (36.02) 611 (40.63) 25 (18.80)
Education (years)
9/10 n (%) 712 (14.29) 22 (6.15) 219 (14.55) 42 (31.34)
13 n (%) 2717 (54.54) 117 (32.68) 871 (57.87) 73 (54.48)
16 n (%) 863 (17.32) 138 (38.55) 216 (14.35) 8 (5.97)
18 n (%) 690 (13.85) 81 (22.63) 199 (13.22) 11 (8.21)
Nutritional score
0 Points n (%) 89 (1.79) 5 (2.11) 47 (3.13) 2 (1.50)
1 Points n (%) 1099 (22.05) 56 (23.63) 303 (20.20) 33 (24.81)
2 Points n (%) 1916 (38.44) 99 (41.77) 662 (44.13) 52 (39.10)











Age (years) Mean (SD) 55.55 (±11.59) 61.54 (±8.65) 47.73 (±10.87) 53.06 (±9.85)
Observation period (years) Mean (SD) 5.51 (±1.07) 5.37 (±0.98) 12.03 (±0.99) 12.11 (±0.99)
Anthropometry
Height (m) Mean (SD) 1.75 (±0.07) 1.74 (±0.07) 1.76 (±0.07) 1.75 (±0.07)
Weight (kg) Mean (SD) 84.59 (±12.65) 92.80 (±14.74) 83.96 (±11.97) 92.71 (±13.86)
BMI (kg/m²) Mean (SD) 27.59 (±3.65) 30.63 (±4.23) 27.04 (±3.37) 30.35 (±3.89)
Waist circumference (cm) Mean (SD) 98.02 (±10.26) 107.17 (±10.82) 97.07 (±9.82) 106.73 (±10.32)
Hip circumference (cm) Mean (SD) 102.57 (±7.29) 107.77 (±9.46) 105.32 (±6.44) 109.42 (±6.81)
WHR Mean (SD) 0.95 (±0.06) 0.99 (±0.05) 0.92 (±0.06) 0.97 (±0.06)










































Smoking (pack years) Mean (SD) 16.29 (±21.24) 22.79 (±27.09) 12.25 (±16.39) 19.22 (±24.32)
No or moderate alcohol consumption (≤20 g/day) n (%) 3113 (67.81) 259 (73.37) 904 (69.75) 85 (65.89)
Sports activities (≥1 h/week) n (%) 2125 (45.55) 125 (35.01) 543 (41.90) 32 (25.00)
Education (years)
9/10 n (%) 185 (3.96) 16 (4.48) 90 (6.95) 12 (9.52)
13 n (%) 2193 (46.95) 188 (52.66) 620 (47.88) 60 (47.62)
16 n (%) 1040 (22.27) 83 (23.25) 269 (20.77) 23 (18.25)
18 n (%) 1253 (26.83) 70 (19.61) 316 (24.40) 31 (24.60)
Nutritional score
0 Points n (%) 384 (8.21) 22 (6.13) 140 (10.91) 15 (11.63)
1 Points n (%) 1639 (35.03) 118 (32.87) 482 (37.57) 53 (41.09)
2 Points n (%) 1787 (38.19) 138 (38.44) 468 (36.48) 45 (34.88)
3 Points n (%) 869 (18.57) 81 (22.56) 193 (15.04) 16 (12.40)
BMI, body mass index; T2DM, type 2 diabetes mellitus; WHR, waist-to-hip-ratio; WHtR, waist-to-height-ratio.






















Weight 1.69 (1.53 to 1.88) – 0.68 (0.65 to 0.72) – 1.65 (1.54 to 1.78) – 0.67 (0.64 to 0.70) –
BMI 1.68 (1.52 to 1.86) −0.01 (−0.22 to 0.19) 0.71 (0.68 to 0.75) 0.03 (−0.02 to 0.08) 1.71 (1.59 to 1.85) 0.06 (−0.12 to 0.24) 0.72 (0.69 to 0.74) 0.04 (0.00 to 0.09)
Waist 1.97 (1.75 to 2.22) 0.28 (−0.01 to 0.57) 0.74 (0.71 to 0.77) 0.06 (0.01 to 0.11) 1.81 (1.67 to 1.96) 0.15 (−0.04 to 0.34) 0.74 (0.71 to 0.76) 0.07 (0.03 to 0.11)
WHR 1.55 (1.40 to 1.71) −0.14 (−0.38 to 0.09) 0.72 (0.68 to 0.75) 0.03 (−0.01 to 0.08) 1.64 (1.46 to 1.83) −0.02 (−0.24 to 0.20) 0.69 (0.66 to 0.71) 0.02 (−0.02 to 0.06)
WHtR 1.93 (1.71 to 2.17) 0.23 (−0.06 to 0.52) 0.75 (0.71 to 0.78) 0.06 (0.01 to 0.11) 1.81 (1.66 to 1.97) 0.15 (−0.04 to 0.35) 0.75 (0.72 to 0.77) 0.07 (0.04 to 0.11)
DEGS§ Weight 1.84 (1.59 to 2.12) – 0.72 (0.67 to 0.76) – 1.78 (1.53 to 2.07) – 0.69 (0.64 to 0.74) –
BMI 1.78 (1.56 to 2.03) −0.06 (−0.40 to 0.28) 0.76 (0.72 to 0.80) 0.04 (−0.02 to 0.10) 2.00 (1.72 to 2.33) 0.23 (−0.17 to 0.62) 0.75 (0.70 to 0.79) 0.06 (−0.01 to 0.13)
Waist 2.24 (1.91 to 2.63) 0.40 (−0.04 to 0.84) 0.77 (0.73 to 0.81) 0.05 (−0.01 to 0.12) 2.06 (1.74 to 2.43) 0.28 (−0.14 to 0.70) 0.75 (0.71 to 0.80) 0.07 (0.00 to 0.13)
WHR 1.83 (1.57 to 2.13) −0.01 (−0.39 to 0.37) 0.74 (0.69 to 0.78) 0.02 (−0.04 to 0.08) 2.29 (1.89 to 2.78) 0.52 (0.01 to 1.02) 0.75 (0.71 to 0.79) 0.06 (0.00 to 0.13)
WHtR 2.10 (1.81 to 2.44) 0.26 (−0.14 to 0.66) 0.78 (0.74 to 0.82) 0.06 (0.00 to 0.12) 2.03 (1.71 to 2.40) 0.25 (−0.17 to 0.67) 0.77 (0.73 to 0.81) 0.08 (0.02 to 0.14)
*HRs are adjusted for study region (only in the pooled sample), education, alcohol consumption, smoking (pack-years), sports activities and nutritional score.
†Data of exposure variables are standardised to a mean of 0 and a SD of 1 for these analyses. The calculated HRs relate to a difference of 1 SD.
‡Compared with weight (reference).
§Results are weighted for dropout.





























a 1 SD difference in weight (≙ 13.2 kg) resulted in a HR
of 1.69 (95% CI 1.53 to 1.88). Likewise, in men, a 1 SD
difference in WC (≙10.6 cm) led to a HR of 1.81 (95%
CI 1.67 to 1.96), whereas a 1 SD difference in weight
(≙ 13.0 kg) resulted in a HR of 1.66 (95% CI 1.54 to 1.78).
In the DEGS sample, in men, WHR showed the stron-
gest association with incident T2DM of all anthropomet-
ric markers, whereas in women, WC and WHtR again
were superior to the other markers (lower part of
table 2). The ﬁnding for WHR is contrary to the results
observed in the pooled sample.
When we calculated the ROC AUC for different
anthropometric measurements, we also found compar-
able predictive values for women and men for each indi-
cator of obesity (table 2 and ﬁgure 2). In the pooled
data set in both sexes, WHtR was the strongest predictor
for incident T2DM (AUC women=0.75 (95% CI 0.71 to
0.78); AUC men=0.75 (95% CI 0.72 to 0.77)) with an
AUC difference of 0.06 (95% CI 0.01 to 0.11) and 0.07
(0.04 to 0.11) for women and men, respectively, com-
pared with weight. Predictive values for the other
markers were similar, apart from weight in women, and
weight and WHR in men, which had a lower discrimina-
tive ability. In the DEGS study sample, the ROC AUC
values and HRs as such were slightly higher than in the
pooled sample, but the comparison of predictive ability
between the anthropometric markers was consistent with
the ranking found in the pooled sample.
Looking at the associations observed within the indi-
vidual study regions of the pooled data set (table 3),
standardised HRs were highest for indices that reﬂected
abdominal obesity as well. WC and WHtR had the stron-
gest associations with incident T2DM. For women, HRs
ranged from 1.56 (95% CI 1.10 to 2.20) to 2.33 (95% CI
1.81 to 3.00) for WC, and from 1.58 (95% CI 1.10 to
2.25) to 2.36 (95% CI 1.81 to 3.08) for WHtR. For men,
the HR ranged from 1.60 (95% CI 1.35 to 1.91) and
2.25 (95% CI 1.73 to 2.92) for WC to 1.64 (95% CI 1.33
to 2.01) and 2.40 (95% CI 1.81 to 3.19) for WHtR.
In age-stratiﬁed analyses we found smaller effects in
participants ≥65 years compared with younger partici-
pants (ﬁgure 3). However, the pattern of larger
Figure 2 ROC curves of five anthropometric markers with respect to incident T2DM (BMI, body mass index; ROC, receiver
operator characteristic; T2DM, type 2 diabetes mellitus; WC, waist circumference; WHR, waist-to-hip-ratio; WHtR,
waist-to-height-ratio).
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estimated effects for WC and WHtR was consistent
across age groups in the pooled sample and the DEGS
study as well as in the meta-analyses, except for the
highest HR for WHR in older participants in DEGS (HR
for WHR in women 2.15 (95% CI 1.47 to 3.13); HR men
3.50 (95% CI 1.64 to 7.46)).
DISCUSSION
We investigated the association between different
anthropometric measurements and the incidence of
T2DM in a study population consisting of four prospect-
ive population-based cohorts located in different regions
of Germany, as well as in a nationwide population.
Overall, we found consistently stronger associations with
incident T2DM for markers reﬂecting abdominal obesity
(ie, WC and WHtR) except for WHR. We also found
advantages in discriminative ability between diabetic and
non-diabetic participants for the same markers (WC and
WHtR), for example, in the pooled sample at a speciﬁ-
city of 70%, 5 more T2DM cases of the 100 would be
identiﬁed when using WHtR compared with BMI.
However, the differences in the AUCs are small and
need to be further validated in independent inter-
national cohorts.
Other investigation groups have conducted similar
analyses with comparable results regarding the strength
of association as well as the discriminative ability.
Schneider et al12 found WHtR to have the best discrim-
inative ability compared with WHR, WC, HC and BMI in
a cross-sectional analysis. In another cross-sectional
study, Bhowmik et al13 calculated ROCs and found the
AUC of WHR, WC and WHtR to be superior to BMI.
Folsom et al16 conducted a prospective study and found
the strongest association of WC with incident T2DM as
compared with WHR and BMI, using quintiles of
anthropometric measures. Findings from several
meta-analyses were inconsistent. A meta-analysis of longi-
tudinal studies was performed by Kodama et al,15 while
Lee et al14 performed a meta-analysis of mainly cross-
sectional studies in Asian populations. Both
meta-analyses found WHtR to be more strongly asso-
ciated with T2DM than WC, WHR or BMI. Contrary to
these results, Vazquez et al17 found no difference
between the anthropometric markers when they studied
WHR, WC and BMI in another meta-analysis of longitu-
dinal studies.
The ﬁnding of an apparent advantage of markers of
central obesity over BMI or weight alone observed in
most studies can probably be explained by the physio-
logical functions of visceral fat tissue, which is known to
have endocrine functions and to be an independent risk
factor for T2DM.17 38 The weaker predictive ability of
WHR observed in our study is contrary to some of the
prior studies,13 17 but consistent with ﬁndings of some
others.12 15 16 The fact that WHR seems to be inferior in
predicting diabetes could be explained by the weaker
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the correlation between WC and visceral fat, thus being
a weaker marker of visceral fat tissue.39 HC—which is an
inherent component of WHR—can reﬂect different
components, such as muscle mass, fat mass and skeletal
features, while WC mainly reﬂects visceral organs and
abdominal fat and thus is a better surrogate marker of
visceral fat tissue.40
Comparing our results with those of the studies afore-
mentioned, caution is needed because of differences in
design and cohort characteristics. Schneider et al12 used
a cross-sectional design so their results cannot be dir-
ectly compared with those of our study; Bhowmik et al13
conducted their study in an Asian cohort, where they
found considerably lower cut-off values for risk of T2DM
than were found in our Western populations. However,
different thresholds of risk for different ethnicities have
already been suggested; for example, the threshold for
WC is lower for South Asians, Chinese and Japanese
than for Europeans.41
When we compared the study regions among each
other, the advantage of markers of abdominal adiposity
over other anthropometric indices was consistent across
most studies. Men in KORA and DEGS are the exceptions
because in these groups, the strongest associations were
observed for WHR, possibly due to cohort differences.
Persistence of the estimated associations was also found
when stratifying the sample by age (<65 vs ≥65 years) in
the pooled sample except for the older group in DEGS,
which was very small (n=112 women and 110 men) and
showed imprecise results. In a meta-analysis of DEGS and
the pooled sample in both age groups, WC and WHtR
showed the strongest associations.
In the age stratiﬁed meta-analyses, we found consist-
ently smaller effects of anthropometric markers on
Figure 3 Meta-analyses of HRs for the association between anthropometric markers and T2DM, stratified by age (BMI, body
mass index; T2DM, type 2 diabetes mellitus; WC, waist circumference; WHR, waist-to-hip-ratio; WHtR, waist-to-height-ratio).
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diabetes risk in individuals aged ≥65 years. Although the
difference is small, this ﬁnding indicates a lower import-
ance of anthropometric markers in predicting diabetes
in the elderly. This ﬁnding needs to be conﬁrmed in
independent samples.
Considering all the results observed, we recommend
paying greater attention to those markers that represent
visceral obesity, such as WC and WHtR. Although all
investigated markers show an association with incident
T2DM, WC and WHtR show the most consistent associa-
tions in all analyses for the studied population.
Our study offers strengths and limitations in terms of
study design and methods. Among the strengths, we can
list the following: we used data from four prospective
planned population-based42 studies from different
regions in Germany, as well as data from a nationwide
survey, resulting in a large study sample. The prospective
design of our original studies is a main advantage, as
certain research question cannot be answered by cross-
sectional studies because of unclear temporality between
anthropometric markers such as exposure and occur-
rence of T2DM. The comparable design and methods as
well as the availability of raw data from CARLA, KORA,
RECALL and SHIP, allowed us to pool the data instead
of conducting a meta-analysis. Using the DEGS sample,
we had the opportunity to compare a nationwide survey
to the pooled data set. We used several statistical instru-
ments such as the transformation of measurements to
units of SD in order to make HRs comparable, as well as
comparison of AUCs to investigate the consistency of the
results. Furthermore, we corrected for the interval-
censored character of the data and the possibility of late
entry with the help of the Weibull model. Another
strength is the selection of covariates applying the
theory of directed acyclic graphs.37
However, there are some limitations to our study. For
example, information on family history of T2DM, which
is a potential confounder of the association of anthropo-
metric markers and diabetes, was lacking in some
studies and thus could not be used for our analyses.
Other limitations include the deﬁnition of T2DM and
medication use via self-reported information instead of
using physician-veriﬁed diagnoses or the results from an
oral glucose tolerance test. Therefore, it is likely that the
incidence of self-reported T2DM is an underestimation
of the true incidence due to undetected and unknown
cases of T2DM. In general, the speciﬁcity of self-
reported T2DM can be considered as high, whereas its
sensitivity is relatively low.43 This means that a bias due
to undetected cases could be possible in this study.
However, Xu et al’s44 investigation showed WC and
WHtR as having stronger associations than other
anthropometric markers with undiagnosed T2DM as
well.
Although examination methods used in the participat-
ing studies were very similar, small differences exist
regarding HC, as described in the method section. To
reduce the effect of variability in the examination
methods, we adjusted all regression models for the study
region.
Furthermore, loss to follow-up could have inﬂuenced
our results, because drop outs could be systematically
different from participants who attended the follow-up
investigation. However, loss to follow-up in the regional
studies was small and analyses in the nationwide DEGS
study, where follow-up non-response was more substan-
tial, were adjusted for drop outs via inverse weighting
from propensity score models.
Overall, our results may be affected by heterogeneity
between studies that could not be captured by the expli-
cit adjustment for the study effects that we performed.
To investigate this, we assessed heterogeneity by estimat-
ing I2 (and the corresponding χ2 test) before and after
correcting for the study sides in our analyses.
Heterogeneity ranged from I2=0% to I2=67% (p>0.05
except for analysis of BMI in men (p=0.03)) between
effects of regional studies and I2=0% to I2=89% (p>0.05
except for analysis of WHR in men (p=0.003)) between
effects in the meta-analyses of pooled regional studies
and nationwide DEGS study. This means that, both
between regional studies and between the pooled data
set and DEGS, heterogeneity was present in varying
degrees.
Another limitation is the fact that we had to work with
interval-censored data because the exact date of diagno-
sis was not available. There might be slight variations in
the studies’ anthropometric measuring methods, but we
corrected for this by adjusting for the study.
In order to encourage use of measures of abdominal
obesity in clinical settings, a lack of conﬁdence in meas-
uring body circumferences45 could be overcome by
using alternative measurement methods such as pho-
tonic scanning rather than ﬂexible tape. These methods
are more precise,46 but the instruments are expensive
and therefore only suitable for speciﬁc applications. A
ﬁrst step to achieve better comparability could be stand-
ardisation of measuring methods. An implication of our
study results for clinical practice might be that, based on
our ﬁndings, general practitioners should be encour-
aged to pay close attention to the distribution of body
fat of their patients when assessing the risk for T2DM,
since visceral fat is more hazardous than evenly distribu-
ted body fat. Although there is a high level of evidence
for the importance of WC, this knowledge is not often
applied in clinical practice by using the respective
measurements.
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